Inhibitors of mast cells as well as P-selectin have been tested clinically leading to reduced VOC in SCD without known adverse events (Kutlar et al., 2012; Kutlar and Embury, 2014; Ataga et al., 2017). Here, SELP is linked to Schnyder corneal dystrophy.